Partnership aims to accelerate COVID-19 vaccine
The development, manufacture, and distribution of a COVID-19 vaccine candidate is the goal of a new partnership that includes the Coalition for Epidemic Preparedness Innovations, CSL, and the University of Queensland. Read More
Sorrento moves forward with COVID-19 prophylactic drug
Sorrento has completed preclinical testing of STI-4398 (COVIDTRAP), reporting positive results on the protein's ability to neutralize and inhibit the SARS-CoV-2 virus from infecting angiotensin-converting enzyme 2-expressing Vero/E6 cells. Read More
Healios advances stem cell research line
Biotechnology company Healios has successfully established a proprietary universal donor cell research line and has characterized the line's gene expression. Read More
Sloan Kettering, Hackensack form immunology collaboration
Memorial Sloan Kettering and Hackensack Meridian Health have formed an immunology research collaboration to support cancer immunotherapy research. Read More
AbbVie licenses antibody technology for COVID-19
AbbVie, Harbour BioMed, Utrecht University, and Erasmus Medical Center announced that they have entered into a collaboration to develop a novel antibody therapeutic agent to prevent and treat COVID-19. Read More
Evolugate boosts cells used to manufacture COVID-19 vaccines
The company's technology for improving industrial microorganisms can be used to increase the productivity of host cells needed to produce COVID-19 vaccines, according to Evolugate. As a result, vaccine manufacturers will be able to reduce the time it takes to make each dose and to get the vaccines to market, the firm said. Read More
Elixirgen progresses COVID-19 vaccine candidate
Elixirgen Therapeutics said it has finished a preinvestigational new drug meeting with the U.S. Food and Drug Administration for its EXG-5003 COVID-19 vaccine candidate. Read More
Gates Foundation directs $1.6B to Gavi, the Vaccine Alliance
The Bill and Melinda Gates Foundation announced a five-year, $1.6 billion U.S. commitment to Gavi, the Vaccine Alliance, to deliver vaccines to developing countries. The announcement was made at the Global Vaccine Summit 2020 on June 4. Read More
Alligator, Scandion pursue preclinical immunotherapies
Sweden-based Alligator Bioscience and Scandion Oncology inked an agreement to explore the antitumor efficacy of CD40 antibody mitazalimab in combination with SCO-101 and chemotherapy in preclinical tumor models. Read More
ImmunoPrecise, NIH, Integrated Biotherapeutics test antibodies for COVID-19
ImmunoPrecise Antibodies announced that it is collaborating with the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health (NIH) and Integrated Biotherapeutics to study molecular binding interactions of therapeutic antibody candidates for COVID-19. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter